Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2023-03-31 00:00:00 ET · period of report 2023-03-29 · accession 0001209191-23-021947 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-31 | 2023-03-29+ | TYRA | Harris Todd | CEO, Dir | M - OptEx | $2.25 | +4,327 | 1.70M | +0.3% | +$9,736 |
| DM | 2023-03-31 | 2023-03-29+ | TYRA | Harris Todd | CEO, Dir | S - Sale+OE | $16.08 | -4,327 | 1.70M | -0.3% | -$69.6K |
| DM | 2023-03-31 | 2023-03-29+ | TYRA | Harris Todd | CEO, Dir | M - OptEx | $0.00 | -4,327 | 400.0K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-30 | M | A | 2,407 | $2.25 | 1,703,683 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-31 | S | D | 500 | $16.05 | 1,701,276 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-29 | S | D | 1,420 | $16.18 | 1,701,276 | D | — | — | |
| 4 | Common | Common Stock | 2023-03-30 | S | D | 2,407 | $16.02 | 1,701,276 | D | — | — | |
| 5 | Common | Common Stock | 2023-03-31 | M | A | 500 | $2.25 | 1,701,776 | D | — | — | |
| 6 | Common | Common Stock | 2023-03-29 | M | A | 1,420 | $2.25 | 1,702,696 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-03-31 | M | D | 500 | $0.00 | 399,537 | D | $2.25 · — to 2031-03-09 | 500 Common Stock | (F2) 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date. |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-03-29 | M | D | 1,420 | $0.00 | 402,444 | D | $2.25 · — to 2031-03-09 | 1,420 Common Stock | (F2) 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date. |
| 9 | Derivative | Stock Option (Right to Buy) | 2023-03-30 | M | D | 2,407 | $0.00 | 400,037 | D | $2.25 · — to 2031-03-09 | 2,407 Common Stock | (F2) 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date. |